+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
NeuBase Therapeutics, Inc. - logo
Allergic Conjunctivitis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Allergic Conjunctivitis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 85 Pages
  • Global
From
Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 218 Pages
  • Global
From
DME Therapies Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

DME Therapies Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • February 2024
  • 96 Pages
  • Global
From
Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 3237 Pages
  • Global
From
Back of the Eye Disorders: Novel Drugs and Delivery Technologies, 2017-2030 - Product Thumbnail Image

Back of the Eye Disorders: Novel Drugs and Delivery Technologies, 2017-2030

  • Report
  • January 2018
  • 292 Pages
  • Global
From
Huntington Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Huntington Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 299 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • March 2024
  • 1300 Pages
  • Global
From
Muscular Dystrophy - Pipeline Review, H2 2020 - Product Thumbnail Image

Muscular Dystrophy - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 287 Pages
  • Global
From
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024 - Product Thumbnail Image

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024

  • Report
  • March 2024
  • 700 Pages
  • Global
From
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2016-2024 - Product Thumbnail Image

Asset Purchase Deals in Pharmaceuticals and Biotechnology 2016-2024

  • Report
  • March 2024
  • 300 Pages
  • Global
From
Global RNA Therapy Market by Technology (Enabled Technologies, Enabling Technologies), Indication (Cancer, Cardiovascular, Genetic Disorders), End User - Forecast 2023-2030 - Product Thumbnail Image

Global RNA Therapy Market by Technology (Enabled Technologies, Enabling Technologies), Indication (Cancer, Cardiovascular, Genetic Disorders), End User - Forecast 2023-2030

  • Report
  • March 2024
  • 197 Pages
  • Global
From
Myotonic Dystrophy - Pipeline Insight, 2024 - Product Thumbnail Image

Myotonic Dystrophy - Pipeline Insight, 2024

  • Drug Pipelines
  • February 2024
  • 80 Pages
  • Global
From
Global Cancer Cachexia Market by Therapy (Combination Therapies, Corticosteroids, Progestogens), Functionality (Appetite Stimulators, Weight Loss Stabilizers), Distribution Channel - Forecast 2024-2030 - Product Thumbnail Image

Global Cancer Cachexia Market by Therapy (Combination Therapies, Corticosteroids, Progestogens), Functionality (Appetite Stimulators, Weight Loss Stabilizers), Distribution Channel - Forecast 2024-2030

  • Report
  • March 2024
  • 198 Pages
  • Global
From
Fibroblast Growth Factor 2 (FGFR2) - Pipeline Insight, 2024 - Product Thumbnail Image

Fibroblast Growth Factor 2 (FGFR2) - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Fibroblast Growth Factor 2 Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Fibroblast Growth Factor 2 Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2021
  • 77 Pages
  • Global
From
Alpha Synuclein - Pipeline Review, H1 2020 - Product Thumbnail Image

Alpha Synuclein - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 150 Pages
  • Global
From
Huntington Disease - Pipeline Review, H1 2020 - Product Thumbnail Image

Huntington Disease - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 390 Pages
  • Global
From
Leucine Rich Repeat Serine/Threonine Protein Kinase 2 - Pipeline Review, H2 2020 - Product Thumbnail Image

Leucine Rich Repeat Serine/Threonine Protein Kinase 2 - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 73 Pages
  • Global
From
Leucine Rich Repeat Serine Threonine Protein Kinase 2 - Pipeline Review, H2 2019 - Product Thumbnail Image

Leucine Rich Repeat Serine Threonine Protein Kinase 2 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 66 Pages
  • Global
From
Ohr Pharmaceutical, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Ohr Pharmaceutical, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • April 2024
  • 50 Pages
From
Loading Indicator